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INTRODUCTION
Malaria  causes about 11% of maternal deaths in
Nigeria.1 Malaria complicates 8.4% to 58.1% of
pregnancies in Nigeria.2,3 Pregnant women in their first
or second pregnancies are particularly susceptible to
malaria.4 Placental parasitaemia limits transfer of
nutrients and oxygen to the foetus, leading to intra-
uterine growth restriction, low birth weight or
intrauterine death.5
The World Health Organization (WHO)’s guidelines
included at least two doses of  intermittent preventive
treatment in pregnancy (IPTp) after quickening,
consistent use of insecticide-treated nets (ITNs), and
effective case management of malaria.6 The most
recent guideline recommends that IPTp is commenced
from 14 weeks’ gestational age,7 then subsequently, at
least one month apart at each scheduled antenatal visit
until delivery (with no upper limit on the number of
doses).7 This is, however, yet to be taken up by many
facilities.8,9 The updated Nigerian National Guideline’s10
uptake has been slow; the initial policy is still in use in
many places, including the study area.
Several studies have shown the impact of IPTp on
prevalence of  malaria in pregnancy.11,12,13 Direct
Observation Therapy (DOT) is recommended for
IPTp to ensure compliance.6 This is however not done
in many clinic settings due to the high patient load, the
medication not being dispensed free, or the
impracticability of making drinking water available for
clients. In rural South-west Nigeria, pregnant women
did not use IPTp because of their uncertainty of drug
safety in pregnancy (even though prescribed by their
caregivers); many also say they would have used the
drugs if  allowed to bring their own water or cups.14
In low-resource environments such as this, availability
of potable water and the unhygienic sharing of public
cups, are reasonable deterrents to DOT.
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ABSTRACT
Background: Malaria complicates up to 58.1% of pregnancies in Nigeria.
Preventive measures include intermittent preventive treatment and consistent use
of  insecticide-treated nets. However, uptake of  these interventions can often be
sub-optimal.
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used prescribed sulphadoxine-pyrimethamine prophylaxis, 784 (49.9%) women
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preventive measures was not statistically significant (p=0.075).
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Intermittent shortages of  SP, which was being supplied
by the government at the time, also limited DOT of
IPTp.
14
Despite awareness of insecticide-treated nets and their
importance in prevention of malaria, the uptake is
often poor. Reasons proffered include the cost of  the
nets, heat entrapment (in a tropical environment) over
bed space when nets are spread, concerns with toxicity
of insecticide, the mere inconvenience of having to
tuck in a net every day, or even forgetting to use it.15,16
Even though ownership of a bed net does not always
result in its utilization, wide distribution is important
for universal coverage.17
The rationale behind the primary care setting employed
in this study was based on the WHO model of
community-based care, described as “care the
consumer can access nearest to the home, which
encourages participation by the people”.18 The
Comprehensive Community and Home-based Health
Care Model (CCHBHC) is defined as “an integrated
system of care designed to meet the health needs of
individuals, families and communities in their local
settings.”.19 Antenatal care in primary health centres
(PHCs) falls under this definition. The investigators thus
expected that the findings would mirror the community
as closely as possible.
This study aimed to determine the prevalence of
malaria in peri-urban and rural communities of Ibadan,
Nigeria and assess its association with the use of malaria
preventive measures.
MATERIALS AND METHODS
This was a community-based,19 cross-sectional study
of pregnant women recruited from selected PHCs
selected by mixed methods. Of  the eleven Local
Government Areas (LGAs) in Ibadan, South-West
Nigeria, six of them are peri-urban and rural. Three
of these six LGAS were randomly selected for the
study: Egbeda, Lagelu, and Ona-Ara. Fourteen PHCs
in these LGAs were purposively sampled (6 from
Lagelu, 4 from Egbeda and 4 from Ona-Ara LGA)
based on their relatively higher patient loads. Ethical
approval was obtained from the Oyo State Research
Ethical Review Committee (reference number AD 13/
479/571).
The study tool was a structured questionnaire; validated
by colleagues’ reviews and by a pilot of ten antenatal
clients at the University College Hospital, Ibadan. It
was administered by trained research assistants after
patient’s written consent was obtained. At least two
doses of IPTp-SP were routinely prescribed in the
study centres as from the second trimester, four weeks
apart. ITNs were also routinely supplied to all pregnant
women at their first visit. This was documented on
their appointment cards when it was supplied; all
participants in the study had received nets.  A Likert
scale was employed to determine the regularity of  ITN
use (“never”, “seldom”, “sometimes”, “often” and
“always”); those who stated “often” or “always” were
described as those who used ITNs. Patients were to
be excluded if they were on alternative malaria
prophylaxis or on cotrimoxazole prophylaxis for HIV
infection.  Participants were included if they had
booked at least four weeks before recruitment.
Consecutive, eligible patients were recruited as
participants. Blood film for malaria parasites were
evaluated at this time. Malaria parasites were tested
using the standard thin and thick film, Giemsa staining
and x1000 microscopy view, as described in WHO’s
standard operating procedures for malaria microscopy
evaluation.20 The slides were prepared and read by
two trained laboratory scientists. Every tenth slide was
re-assessed by a senior scientist for quality control, but
no significant differences were found. The study’s
explanatory variables were the use of bed nets and
chemoprophylaxis; the primary outcome was presence
of peripheral malaria parasitaemia.
Dual data entry was done using EpiData version 4
(The EpiData Association, Odense, Denmark), after
which data checks were done by verification and
consistency checks and specific data editing was made.
All data were re-coded during data cleaning with none
linked to individuals. Data were then transferred to
IBM® SPSS Statistics® version 20.0 (IBM Corp.,
Armonk, USA) for analysis. Descriptive and bivariate




One thousand, five hundred and seventy women
completed the questionnaires and had malaria parasite
tests done out of the total 1,645 that were recruited
giving a 95.4% response rate. The demographic data
of  participants are summarized in Table 1. Most of
them were within the age bracket 20-29 years, with a
mean age of  27.1 ± 5.7 years. Over a third of  them
were primigravid. Most participants were recruited in
the third trimester (925; 59.1%), while 579 (37.0%)
were sampled in the second trimester. The average
gestational age at booking was 21.1 ± 6.6 weeks.
Prevalence of malaria parasitaemia
Of the 1,570 malaria parasite tests done, 67 women
had positive results giving a malaria prevalence of
4.3%. Forty-three (64.2%) women of  the 67 that tested
positive for malaria had associated symptoms of
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malaria (fever, malaise, nausea and/or vomiting,
headache and loss of appetite). The rest (24; 35.8%)
had asymptomatic malaria. Multigravidae were
significantly less likely to have malaria parasites, while
primigravidae were more likely to (p=0.012).
Utilization of malaria prevention methods
All the participants were prescribed SP; no one was
prescribed any alternative prophylaxis. There were six
(0.38%) HIV-positive participants; however, none of
them were on cotrimoxazole in place of  SP. Only 438
(27.9%) of the participants used sulphadoxine-
pyrimethamine as prescribed for them. Most of this
sub-group had used only one dose (333 women;
21.2%), while 97 (6.2%) had two doses and 8 (0.5%)
had three doses. The first dose was used averagely at
23.3 ± 6.7 weeks. The second dose was used at
averagely 27.8 ± 7.6 weeks. Seven hundred and eighty-
Malaria Parasite
Variable Positive (%) Negative (%) P-value
Age
≤19 6 (8.96) 75 (4.99) 0.248
20-24 21 (31.34) 460 (30.61)
25-29 22 (32.84) 467 (31.07)
30-34 12 (17.91) 333 (22.16)
35-39 3 (4.48) 141 (9.38)
≥40 3 (4.48) 27 (1.80)
Level of education
None 0 (0.00) 22 (1.47) 0.571
Primary 6 (8.96) 193 (12.87)
Secondary 49 (73.13) 1020 (68.00)
Tertiary 12 (17.91) 265 (17.67)
Husband’s level of education
None 0 (0.00) 17 (1.14) 0.455
Primary 3 (4.48) 100 (6.69)
Secondary 47 (70.15) 919 (61.47)
Tertiary 17 (25.37) 459 (30.70)
GA at blood sampling
First trimester 3 (4.48) 57 (3.81) 0.957
Second trimester 25 (37.31) 554 (37.01)
Third trimester 39 (58.21) 886 (59.19)
Parity
Para 0 34 (50.75) 530 (35.26) 0.012 *
Para 1 19 (28.36) 367 (24.42)
Para 2-4 13 (19.40) 578 (38.46)
≥Para 5 1 (1.49) 28 (1.86)
Ethnicity
Yoruba 64 (96.97) 1434 (95.98) 0.816
Igbo 2 (3.03) 31 (2.07)
Hausa 0 (0.00) 7 (0.47)
Others 0 (0.00) 22 (1.47)
Table 1: Demographic characteristics of  participants
*Significant at 5% level of significance







None 31 (46.27) 553 (36.79) 584 (37.20)) 6.898 0.075
IPT only 8 (11.94) 194 (12.91) 202 (12.87)
ITN only 25 (37.31) 523 (34.80) 548 (34.90)
IPT & ITN 3 (4.48) 233 (15.50) 236 (15.03)
Table 2: Association between use of  preventive measures and malaria parasitaemia
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four (49.9%) women used ITNs regularly during
pregnancy. Only 15% (236) of  the participants used
both ITNs as well as at least one dose of  IPTp-SP.
Association between compliance with malaria
prevention methods and malaria parasitaemia
Table 2 shows that there was no statistically significant
relationship between the reported compliance with
either of the two preventive measures studied and the
prevalence of malaria parasitaemia. Participants who
used both preventive measures were less likely to have
parasitaemia, howbeit, insignificantly associated. Table
3 shows there were no significant associations between
symptomatic malaria and the reported use of these
preventive measures, though women who used both
measures also tended to be less likely to suffer malaria
symptoms.
DISCUSSION
Prevalence of malaria parasitaemia
The prevalence of malaria parasitaemia in pregnant
women of peri-urban and rural communities of
Ibadan in south-west Nigeria, was much lower than
in other national sub-regions: 42% in the north-east,21
58% in the south-south,3 and 92-99% in the south-
east.22,23 The sample size was relatively larger than most
of these other studies; and most of the participants
were of low parity (women of low parity have the
highest risk of  malaria in pregnancy, as was also
corroborated in this study).4,24 The prevalence is
therefore likely to be reliable for the studied
population. Other prevalence figures from the same
geographic region ranged from a low 8.4%,2 to higher
21.3% and 41.8%, respectively.25,26 These higher figures
were derived from relatively smaller studies, as found
in the other subnational regions.
About a third of participants with peripheral
parasitaemia had asymptomatic malaria. Other authors
have recorded higher prevalence of asymptomatic
parasitaemia: 48% 27 and 89% 2 (the latter study used
fever only to determine symptomatic malaria, thus the
very low prevalence).
Utilization of malaria prevention methods
Anecdotal evidence shows that ITNs are routinely
distributed free in the study areas. However, only half
of the study population claim to sleep under these
nets.  Reasons discussed previously in the Introduction
may explain this.15,16 Fifty-three percent of  the general
population in sub-Saharan Africa are estimated to sleep
under nets, which is accredited to the improved access
to these nets.28 However, evidence from meta-analysis
shows that even though getting free nets improve
ownership compared to paying a subsidized cost or
in full; it had no effect on its utilization.29 Educational
intervention was found to have a positive effect on its
use; therefore, more emphasis should be placed on
health education about this control strategy.29
About 55% of pregnant women in sub-Saharan Africa
have at least one dose of  IPTp-SP during pregnancy,
while 31% have three doses.28 Yet, less than a third of
this study’s participants had had at least one dose. SP
is neither supplied free at the study areas nor dispensed
under direct observation, so this maybe an obvious
explanation for its poor utilization as compared to
ITNs which are supplied free. IPTp use has been
shown to reduce the risk of  malaria in pregnancy,8,13
and strategies to increase its uptake are therefore
desired. The World Health Organization noted in its
current guidelines7 that its previous recommendation
for at least two doses6 resulted in countries (including
Nigeria) formulating their national programs to target
the administration of  two doses in pregnancy. This
has been modified to unlimited monthly doses, with a
target of  at least three doses.7 The findings of  this
study were far behind these guidelines, as most
providers have been slow to implement the update.
The late gestational age at booking that was prevalent
in this study, is not uncommon in the study area. In the
Demographic and Health Survey, only 17.6% booked
in the first trimester; median pregnancy age of booking
was at 5 months.30 In a similar local study, 2.5% booked
in the first trimester, while the average booking time
was 23.5 weeks.25 Late booking limits the benefit that
can be derived from preventive measures; IPT should
IPT/ITN
use







None 10 (41.67) 21 (48.84) 31 (46.27) 4.2896 0.258
IPT only 1 (4.17) 7 (16.28) 8 (11.94)
ITN only 11 (45.83) 14 (32.56) 25 (37.31)
IPT & ITN 2 (8.33) 1 (2.33) 3 (4.48)
Table 3: Association between use of  preventive measures and symptomatic malaria
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have been commenced from the early second trimester.
Despite the fact that most participants were recruited
in the third trimester, low utilization of SP was found.
Late booking may also have contributed to this.
Association between compliance with malaria
prevention methods and malaria parasitaemia
The recommended combination of both preventive
measures (as self-reported) resulted in the lowest
prevalence of both parasitaemia and symptoms, as
expected. However, despite a lack of statistical
significance (which may be due to the low prevalence
of malaria in pregnancy in the study area), this study
suggests that the use of  bed nets only is associated
with a lower prevalence of malaria, when compared
to the use of  chemoprophylaxis only. As SP is paid
for out-of-pocket and used at home, it may be more
difficult to ensure full compliance. Targeting a hundred
percent of these pregnant women sleeping under a
net may currently be more feasible in the study area, as
nets are distributed free at antenatal clinics.
The study was limited in that chemoprophylaxis and
ITN use were not observed, but rather reported. This
may limit the interpretation of the findings; however,
the low prevalence of  malaria suggests that the claims
to adherence were probably not embellished. The
study also assumed that most clients booked after the
first trimester, as is often so in the study area. The
assumption is that participants would have been
prescribed IPT at their first visit, before being recruited
at subsequent visits. This assumption is not always so,
as a few register early, so may not have been prescribed
IPT before recruitment.
CONCLUSION
This study found a low prevalence of malaria among
pregnant women in selected rural and peri-urban
communities in Ibadan, with reported uptake of
preventive measures in about two-thirds of them.
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